BLUE vs. OMEX

Last updated Apr 2, 2026

Compare and contrast key facts about bluebird bio, Inc. (BLUE) and Odyssey Marine Exploration, Inc. (OMEX).

Performance

BLUE vs. OMEX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in bluebird bio, Inc. (BLUE) and Odyssey Marine Exploration, Inc. (OMEX). The values are adjusted to include any dividend payments, if applicable.

BLUE vs. OMEX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BLUE bluebird bio, Inc.	0.00%	-40.41%	-69.78%	-80.06%	-30.73%	-64.35%	-50.69%	-11.54%	-44.30%	188.65%
OMEX Odyssey Marine Exploration, Inc.	-58.67%	172.22%	-84.52%	19.85%	-25.38%	-26.76%	122.57%	-4.20%	-11.67%	10.23%

Fundamentals

Total Revenue (TTM) BLUE : $103.95M OMEX : $467.12K
Gross Profit (TTM) BLUE : $28.19M OMEX : -$1.46M
EBITDA (TTM) BLUE : -$115.82M OMEX : $1.32B

Returns By Period

BLUE

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

OMEX

• 1D: -2.88%
• 1M: -51.20%
• YTD: -58.67%
• 6M: -57.81%
• 1Y: 107.69%
• 3Y*: -37.07%
• 5Y*: -34.77%
• 10Y*: -20.70%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BLUE vs. OMEX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OMEX

OMEX Risk / Return Rank: 71
OMEX Sharpe Ratio Rank: 61
OMEX Sortino Ratio Rank: 86
OMEX Omega Ratio Rank: 79
OMEX Calmar Ratio Rank: 67
OMEX Martin Ratio Rank: 64

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BLUE vs. OMEX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for bluebird bio, Inc. (BLUE) and Odyssey Marine Exploration, Inc. (OMEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	BLUE	OMEX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.58	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.24	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.17	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.04	—

Correlation

The correlation between BLUE and OMEX is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BLUE vs. OMEX - Dividend Comparison

Neither BLUE nor OMEX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	BLUE	OMEX	Difference
Max Drawdown Largest peak-to-trough decline	—	-99.70%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-81.36%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-96.05%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-97.40%	—
Current Drawdown Current decline from peak	—	-99.19%	—
Average Drawdown Average peak-to-trough decline	—	-71.41%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	40.16%	—

Volatility

Volatility by Period

	BLUE	OMEX	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	38.38%	—
Volatility (6M) Calculated over the trailing 6-month period	—	87.32%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	188.02%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	142.82%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	119.79%	—

Financials